GSK announces $2.2 billion deal, targeting once-per-three-month food allergy drug

by | Jan 20, 2026 | Stock Market

The growing scourge of food allergies drove U.K. heavyweight GSK to announce a $2.2 billion deal on Tuesday.

Article Attribution | Read More at Article Source